These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Further studies on the abnormal factor X (factor X Friuli) coagulation disorder: a report of another family. Girolami A; Lazzarin M; Scarpa R; Brunetti A Blood; 1971 May; 37(5):534-41. PubMed ID: 4995085 [No Abstract] [Full Text] [Related]
4. THE EFFECT OF LANTHANIDES AND ACTINIDES ON BLOOD COAGULATION. II. ASSAY OF A NEW SERUM THROMBOPLASTIC FACTOR VULNERABLE TO THESE ELEMENTS AND ITS VARIATIONS IN HEALTH AND DISEASE. COLMAN R; ALEXANDER B J Clin Invest; 1964 Apr; 43(4):720-7. PubMed ID: 14149923 [No Abstract] [Full Text] [Related]
6. Detection and clinical significance of PIVKA. Veltkamp JJ Mayo Clin Proc; 1974 Dec; 49(12):923-4. PubMed ID: 4444340 [No Abstract] [Full Text] [Related]
7. Factor X Friuli coagulation disorder. Report of a newly recognized patient and some considerations on the frequency of the disease in the Friuli area. Girolami A; Falomo R; De Marco L; Patrassi G Acta Haematol; 1976; 56(1):27-38. PubMed ID: 822673 [TBL] [Abstract][Full Text] [Related]
8. Further studies on the abnormal factor X (factor X Friuli) coagulation disorder. A report of another family. Girolami A; Lazzarin M; Scarpa R; Brunetti A Haematol Lat; 1970; 13(2):169-83. PubMed ID: 5504043 [No Abstract] [Full Text] [Related]
9. Abnormal factor X (factor X Friuli) coagulation disorder. The heterozygote population. A study of 57 subjects. Girolami A; Brunetti A; Bareggi G; Cella G Acta Haematol; 1974; 51(1):40-50. PubMed ID: 4217072 [No Abstract] [Full Text] [Related]
10. A family with heterozygous factor X Friuli defect outside Friuli. Girolami A; Lazzarin M; Procidano M; Luzzatto G Blut; 1983 Mar; 46(3):149-54. PubMed ID: 6824795 [TBL] [Abstract][Full Text] [Related]
11. Congenital deficiency of vitamin K-dependent coagulation factors associated with central nervous system anomalies. Puetz J; Knutsen A; Bouhasin J Thromb Haemost; 2004 Apr; 91(4):819-21. PubMed ID: 15045146 [No Abstract] [Full Text] [Related]
12. [Supervision of anticoagulant therapy with the aid of the factor X determination]. Dahl J; Remde W Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 85(1):96-102. PubMed ID: 4165545 [No Abstract] [Full Text] [Related]
14. [Hepato-quick--a new thromboplastin time system: a comparison with normotest and thrombotest (author's transl)]. Fischer M; Falkensammer C Wien Klin Wochenschr; 1974 Oct; 86(19):577-83. PubMed ID: 4432516 [No Abstract] [Full Text] [Related]
15. Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors. Zivelin A; Rao LV; Rapaport SI J Clin Invest; 1993 Nov; 92(5):2131-40. PubMed ID: 8227329 [TBL] [Abstract][Full Text] [Related]
16. Factor X Friuli coagulation disorder. First report of a patient born in Friuli after the description of the disease. Girolami A; Carli A; Falomo R; De Marco L Blut; 1973 Sep; 27(3):151-8. PubMed ID: 4762001 [No Abstract] [Full Text] [Related]
17. A "new" congenital haemorrhagic condition due to the presence of an abnormal factor X (factor X Friuli): study of a large kindred. Girolami A; Molaro G; Lazzarin M; Scarpa R; Brunetti A Br J Haematol; 1970 Aug; 19(2):179-92. PubMed ID: 4989292 [No Abstract] [Full Text] [Related]
18. Role of accessory components in the activation of vitamin K-dependent coagulation factors. van Rijn JL; Zwaal RF; Hemker HC; Rosing J Haemostasis; 1986; 16(3-4):216-26. PubMed ID: 3093336 [TBL] [Abstract][Full Text] [Related]
20. Evidence for a warfarin-sensitive serum factor that participates in factor X activation by Lewis lung tumor cells. Fasco MJ; Wilson AC; Lincoln D; Gierthy J Int J Cancer; 1987 May; 39(5):631-7. PubMed ID: 3570555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]